Literature DB >> 12598658

Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells.

Takaaki Inaba1, Hajime Sano, Yutaka Kawahito, Timothy Hla, Kaoru Akita, Munetoyo Toda, Ikuo Yamashina, Mizue Inoue, Hiroshi Nakada.   

Abstract

Up-regulation of cyclooxygenase-2 (COX-2) and overproduction of prostaglandins have been implicated in the initiation and/or progression of colon cancer. However, it is uncertain in which cells and how COX-2 is induced initially in the tumor microenvironment. We found that a conditioned medium of the colon cancer cell line, LS 180, contained a factor to induce COX-2 in human peripheral blood mononuclear cells. This factor was purified biochemically and revealed to be mucins. A small amount of mucins (approximately 100 ng of protein per ml) could elevate prostaglandin E2 production by monocytes. The mucins induced COX-2 mRNA and protein levels of monocytes in a dose- and time-dependent manner, indicating a COX-2-mediated pathway. We also have examined immunohistochemically the localization of COX-2 protein and mucins in human colorectal cancer tissues. It is noteworthy that COX-2-expressing macrophages were located around the region in which mucins were detectable, suggesting that COX-2 also was induced by mucins in vivo. These results suggest that mucins produced by colon cancer cells play a critical role in the initial induction of COX-2 in the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598658      PMCID: PMC151410          DOI: 10.1073/pnas.0435410100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The central domain of bovine submaxillary mucin consists of over 50 tandem repeats of 329 amino acids. Chromosomal localization of the BSM1 gene and relations to ovine and porcine counterparts.

Authors:  W Jiang; D Gupta; D Gallagher; S Davis; V P Bhavanandan
Journal:  Eur J Biochem       Date:  2000-04

Review 2.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 3.  Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

Authors:  R A Gupta; R N DuBois
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

Review 4.  Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.

Authors:  W L Smith; R M Garavito; D L DeWitt
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

5.  Expression of cyclooxygenase-2 in human gastric carcinoma.

Authors:  A Ristimäki; N Honkanen; H Jänkälä; P Sipponen; M Härkönen
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

Review 6.  Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

Authors:  R N DuBois; F M Giardiello; W E Smalley
Journal:  Gastroenterol Clin North Am       Date:  1996-12       Impact factor: 3.806

7.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

Authors:  T Kawamori; C V Rao; K Seibert; B S Reddy
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

8.  Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

Authors:  M Oshima; J E Dinchuk; S L Kargman; H Oshima; B Hancock; E Kwong; J M Trzaskos; J F Evans; M M Taketo
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

9.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

Authors:  D Hwang; D Scollard; J Byrne; E Levine
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

10.  Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

Authors:  M Tsujii; S Kawano; S Tsuji; H Sawaoka; M Hori; R N DuBois
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  21 in total

Review 1.  Vaccine prevention of cancer: can endogenous antigens be targeted?

Authors:  Louis M Weiner; Rishi Surana; Joseph Murray
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

2.  Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.

Authors:  S Tanaka; A Tatsuguchi; S Futagami; K Gudis; K Wada; T Seo; K Mitsui; M Yonezawa; K Nagata; S Fujimori; T Tsukui; T Kishida; C Sakamoto
Journal:  Gut       Date:  2005-08-05       Impact factor: 23.059

3.  A digest on the role of the tumor microenvironment in gastrointestinal cancers.

Authors:  Martin Augsten; Christina Hägglöf; Cristina Peña; Arne Ostman
Journal:  Cancer Microenviron       Date:  2010-03-07

Review 4.  [Tumor microenvironment in gastrointestinal tumors].

Authors:  B Etschmann; S Gattenlöhner
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Prognostic value of tumor progression-related gene expression in colorectal cancer patients.

Authors:  Miriam E Uhlmann; Milka Georgieva; Martin Sill; Ulrich Linnemann; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-22       Impact factor: 4.553

6.  Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Authors:  Pawel Kalinski; Howard Edington; Herbert J Zeh; Hideho Okada; Lisa H Butterfield; John M Kirkwood; David L Bartlett
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

7.  Effect of astragaloside IV on diabetic gastric mucosa in vivo and in vitro.

Authors:  Ningding Wang; Frederick Siu; Yongbin Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 8.  Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Authors:  Pawel Kalinski
Journal:  Curr Opin Investig Drugs       Date:  2009-06

Review 9.  Cyclooxygenase-2 and its role in colorectal cancer development.

Authors:  Dominique Wendum; Joëlle Masliah; Germain Trugnan; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-09-01       Impact factor: 4.064

Review 10.  Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.

Authors:  Pawel Kalinski; Julie Urban; Rahul Narang; Erik Berk; Ewa Wieckowski; Ravikumar Muthuswamy
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.